In yesterday’s Wall Street session, Medtronic Plc (NYSE:MDT) shares traded at $91.98, down -0.52% from the previous session.
MDT stock price is now 9.10% away from the 50-day moving average and 9.07% away from the 200-day moving average. The market capitalization of the company currently stands at $117.94B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $98 to $105, RBC Capital Mkts Upgraded its rating from Sector Perform to Outperform for Medtronic Plc (NYSE: MDT). On August 21, 2024, Oppenheimer reiterated its ‘Perform’ rating on the stock by increasing its target price from $92 to quote $94, while ‘UBS’ rates the stock as ‘Neutral’
In other news, Wall Brett A., EVP & Pres Neuroscience sold 12,437 shares of the company’s stock on Jan 24 ’25. The stock was sold for $1,119,330 at an average price of $90.00. Upon completion of the transaction, the EVP & Pres Neuroscience now directly owns 40,979 shares in the company, valued at $3.77 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 24 ’25, Officer Wall Brett A. bought 12,437 shares of the business’s stock. A total of $1,119,330 was incurred on buying the stock at an average price of $90.00. A total of 0.08% of the company’s stock is owned by insiders.
During the past 12 months, Medtronic Plc has had a low of $75.96 and a high of $92.68. As of last week, the company has a debt-to-equity ratio of 0.58, a current ratio of 1.84, and a quick ratio of 1.39. According to the stock market information, the enterprise value for the company is $132568342528, which is based on a 28.07 price-to-earnings ratio, a 4.26 price-to-earnings-growth ratio, and a beta of 0.85. The fifty day moving average price for MDT is $84.3064 and a two-hundred day moving average price translates $84.33145 for the stock.
The latest earnings results from Medtronic Plc (NYSE: MDT) was released for 2024-07-26. The net profit margin was 13.00% and return on equity was 8.58% for MDT. The company reported revenue of $7.92 billion for the quarter, compared to $7.7 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 2.77 percent.
